US Edition
AtriCure completes enrolment in trial assessing stroke prevention with AtriClip device
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
AtriCure completes enrolment in trial assessing stroke prevention with AtriClip device
AtriCure has announced the completion of enrolment in the LeAAPS clinical trial—a prospective, randomised, blinded, superiority investigational device exemption (IDE) trial evaluating the AtriClip left atrial appendage (LAA) exclusion system for the prevention of ischaemic stroke and systemic arterial embolism in cardiac surgery patients without a history of atrial fibrillation (AF). The LeAAPS trial was initiated in January 2023, and has enroll…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
